NCT02003222 2025-11-28Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting488 enrolled 13 charts 2 FDA
NCT03589326 2025-11-26A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic LeukemiaTakedaPhase 3 Active not recruiting245 enrolled 15 charts 2 FDA